À Propos de l'Entreprise
- Raison sociale: Sichuan Gowell Pharmaceutical Co., Ltd.
- Pays d'enregistrement: China
- Adresse: SichuanMeishanNew Area, Meishan Economic Development Zone, Sichuan Province • Sichuan
- Année de création: 2011
Description:
Tracing its roots to Guowei Pharmaceutical, founded in 2005 and reorganized as Sichuan Gowell Pharmaceutical in 2011, the company manufactures and exports vitamin D analogs (calcitriol, paricalcitol, eldecalcitol), the rare disease therapy nusinersen, dutasteride, lubiprostone, dotinurad, morinidazole, and omega-3 products including structured triglycerides and refined olive oil — having been first in China to achieve 90% omega-3 ethyl ester purity. The company invests nearly 30% of revenue in R&D, averaging three approved drug launches (starting with nalmefene hydrochloride injection "Lemeng" in 2008 and moxifloxacin hydrochloride API and injection in 2014), operates a provincial enterprise technology center, and offers CRO services across North America, Europe, Asia, the Middle East, Africa, and Australasia.
Activités Commerciales
Principes Actifs Pharmaceutiques (API)
Fabricant de Principes Actifs (API)FabricantExportateur
Formes Pharmaceutiques Finies
FabricantExportateur
Excipients & Additifs
FabricantExportateur
Extraits Naturels & Ingrédients Botaniques
FabricantExportateur
Marchés de Vente
- Western Europe: Austria, Belgium, France
- Northern America: Bermuda, Canada, Greenland, Saint Pierre and Miquelon, United States
- Central America: Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama
- South America: Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Falkland Islands, French Guiana, Guyana, Paraguay, Peru, Suriname, Uruguay, Venezuela
Produits/Services Clés
- Principes Actifs Pharmaceutiques (API): Beraprost sodium, Lubiprostone, Morinidazole, DUTASTERIDE, CALCITRIOL, FERRIC CARBOXYMALTOSE, FERRIC DERISOMALTOSE, Sodium Zirconium Cyclosilicate, Paricalcitol, Eldecalcitol, Teprenone, Refined Olive Oil, Dotinurad, Nusinersen, GalNAc-L96-Succinate,TEA salt, Moxifloxacin hydrochloride, Iron Saccharate, Structured Triglycerides, Sucroferric oxyhydroxide, Upadacitinib Hemihydrate
- Formes Pharmaceutiques Finies: Soft Capsules, Oral solid dosage formulations
- Classification ATC (Anatomique, Thérapeutique, Chimique): Linaclotide, Fish Oil (28% Omega-3 Acids), Fish Oil Triglycerides, Icosapent Ethyl, Omega-3-acid ethyl ester 90, omega-3-acid triglycerides
Nos Produits & Services
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Certifications
Évaluations
(0)
(0)
(0)
(0)
(0)
Commentaires
Filtres :
Trier par :
Aucun commentaire disponible.
Laissez votre note & commentaire